Teladoc Health, Inc. (TDOC) incurred a first-quarter 2024 adjusted loss of 49 cents per share, wider than the Zacks Consensus Estimate of a loss of 47 cents and the year-ago quarter’s loss of 42 cents. The figure was also within management’s expectation of a loss of 55-45 cents.Operating revenues amounted to $646.1 million, which grew 3% year over year and exceeded management’s expectation of $630-$645 million. The top line beat the consensus mark by 1.4%.The quarterly results were hurt by lower visits, sof ...

The onetime telehealth star's luster continued to dim after publishing first-quarter earnings.Like other companies that flew high during the thick of the coronavirus pandemic, Teladoc Health (TDOC -2.40%) has lost significant altitude since then. It'll probably stay at modest levels after releasing its first-quarter financials after market hours Thursday.In reaction the following day, investors traded out of the stock to the point where it closed more than 2% lower in price. This was in marked contrast to t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-37477 ___________ ...

Teladoc Health, Inc. (NYSE:TDOC) Q1 2024 Earnings Call Transcript April 25, 2024 5:00 PM ET Company Participants Adam Vandervoort - Chief Legal Officer Mala Murthy - Acting Chief Executive Officer and Chief Financial Officer Laizer Kornwasser - President of Enterprise Growth and Global Markets. Conference Call Participants Stephanie Davis - Barclays Lisa Gill - JPMorgan Jailendra Singh - Truist Jessica Tassan - Piper Sandler Sean Dodge - RBC Capital Allen Lutz - Bank of America Sarah James - Cantor Fitzgera ...

For the quarter ended March 2024, Teladoc (TDOC) reported revenue of $646.13 million, up 2.7% over the same period last year. EPS came in at -$0.49, compared to -$0.37 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $636.98 million, representing a surprise of +1.44%. The company delivered an EPS surprise of -4.26%, with the consensus EPS estimate being -$0.47.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...

Teladoc (TDOC) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.26%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.22 per share when it actually produced a loss of $0.17, delivering a surprise of 22.73%.Over the last four quarters, the company ...

Cautionary Note • This presentation may include certain non-GAAP financial measures as defined by SEC rules. Teladoc Health believes that the presentation of such non-GAAP financial measures enhances an investor's understanding of the Company's financial performance. Teladoc Health uses certain non-GAAP financial measures for business planning purposes and in measuring the Company's performance relative to that of its competitors. For additional information regarding these non-GAAP financial measures, inclu ...

"We are pleased to report a solid start to the year, with strength in both revenue and adjusted EBITDA in the first quarter," said Mala Murthy, acting chief executive officer and chief financial officer of Teladoc Health. "During this period of transition, our team remains laser focused on our key initiatives, which include building upon our market leadership position; driving increased product penetration through our large installed base of over 90 million virtual care members; and accelerating our bottom- ...

Teladoc Health, Inc. (TDOC) is set to report its first-quarter 2024 results on Apr 25, after the closing bell. Analysts anticipate a robust performance in the Integrated Care segment, although rising costs may partially offset its results. Let’s delve deeper.Factors Impacting TDOCTeladoc’s top line has been benefiting on the back of higher Access Fees, visits and segmental growth in Integrated Care. Growth in U.S. Integrated Care members is likely to have fueled growth in its first-quarter results. Our esti ...

Has the telehealth provider entered value territory?Investor sentiment surrounding Teladoc (TDOC -1.20%) has been bad for a while now. The telemedicine specialist's stock is down 95% from its all-time high in 2021.Teladoc's business boomed during the early days of the COVID-19 pandemic, benefiting enormously by providing at-home virtual care to patients. But like so many of the other "stay-at-home" stocks, Teladoc has struggled mightily since life returned to normal. The company is not currently profitable, ...